Goat F(ab')2 Anti-Human IgG, Mouse ads-PE
Référence 2043-09
Conditionnement : 0.25mg
Marque : Southern Biotech
Contactez votre distributeur local :
Téléphone : +1 850 650 7790
| Isotype | Goat F(ab')2 IgG |
|---|---|
| Isotype Control | Goat F(ab')2 IgG-PE |
| Specificity | Reacts with the heavy chain of human IgG |
| Source | Pepsin digest of goat anti-human IgG (SB Cat. No. 2044) |
| Cross Adsorption | Human IgM and IgA; mouse immunoglobulins and pooled sera; may react with IgG from other species |
| Conjugate | PE (R-phycoerythrin) |
| Buffer Formulation | Phosphate buffered saline containing < 0.1% sodium azide and a stabilizer |
| Clonality | Polyclonal |
| Concentration | 0.25 mg/mL |
| Volume | 1.0 mL |
| Recommended Storage | 2-8°C; Avoid exposure to light; Do not freeze |
| Applications | Quality tested applications for relevant formats include - ELISA FLISA Flow Cytometry 1-5 |
| RRID Number | AB_2795669 |
Documentation
Technical Bulletin Safety Datasheet
Certificate of Analysis Lookup
Enter the Catalog Number and Lot Number for the Certificate of Analysis you wish to view
- 1. Oritani K, Kincade PW. Identification of stromal cell products that interact with pre-B cells. J Cell Biol. 1996;134:771-82. (FC)
- 2. Weih DS, Yilmaz B, Weih F. Essential role of RelB in germinal center and marginal zone formation and proper expression of homing chemokines. J Immunol. 2001;167:1909-19. (FC)
- 3. Heuser C, Ganser M, Hombach A, Brand H, Denton G, Hanisch F, et al. An anti-MUC1-antibody-interleukin-2 fusion protein that activates resting NK cells to lysis of MUC1-positive tumour cells. Br J Cancer. 2003;89:1130-9. (FC)
- 4. Hinton PR, Xiong JM, Johlfs MG, Tang MT, Keller S, Tsurushita N. An engineered human IgG1 antibody with longer serum half-life. J Immunol. 2006;176:346-56. (FC)
- 5. Tunheim G, Schjetne KW, Rasmussen IB, Sollid LM, Sandlie I, Bogen B. Recombinant antibodies for delivery of antigen: a single loop between β-strands in the constant region can accommodate long, complex and tandem T cell epitopes. Int Immunol. 2008;20:295-306. (FC)